IR Reports
IR Release
| No | TITLE | FILE | DATE | COUNT |
|---|---|---|---|---|
| 103 | Transition to a Holding Company |
|
2022.11.23 | 381 |
| 102 | Q3 2022 IR release (Reviewed by External Auditor) |
|
2022.11.14 | 97 |
| 101 | Q3 2022 IR release |
|
2022.10.26 | 610 |
| 100 | Q2 2022 IR release (Reviewed by External Auditor) |
|
2022.08.12 | 155 |
| 99 | Q2 2022 IR release |
|
2022.07.26 | 2014 |
| 98 | Q1 2022 IR release (Reviewed by External Auditor) |
|
2022.05.13 | 165 |
| 97 | Q1 2022 IR release |
|
2022.04.28 | 462 |
| 96 | Q4 2021 IR release (Reviewed by External Auditor) |
|
2022.03.15 | 267 |
| 95 | Notice of the Investment in Bukwang Pharmaceutical |
|
2022.02.22 | 57 |
| 94 | Q4 2021 IR release |
|
2022.02.08 | 796 |
You may need to install Acrobat Reader to view PDF files
